Treatment of Hypertension in Tibetan Adult Population

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 800 participants.

Also called NCT02217852

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 800 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02217852
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02217852. Randomized; no masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2016-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Treatment of Hypertension in Tibetan Adult Population
Condition
Hypertension
Intervention (Drug)
Nitrendipine
Intervention (Drug)
Hydrochlorothiazide
Intervention (Drug)
Captopril,Hydrochlorothiazide
Intervention (Drug)
Beijing hypotensive No.0
Lead sponsor
West China Hospital (class: other)

Record details

Record id
cardio:ct-nct02217852
Content hash
b2ffa1e3c5f1c0a5a820812ea3801e82283dce769e8d7a093ac2723cd552d48e